Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 17362501000001110 | Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 103463001000001115 | Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (Aspen Pharma Trading Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Is a | Lidocaine 400mg/20ml (2%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection 20ml vials | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has excipient | Sodium metabisulfite | false | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has excipient | Paraben and/or paraben derivative | false | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has active ingredient | Epinephrine bitartrate | false | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Is a | Xylocaine with Adrenaline | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has excipient | Hydroxybenzoates | false | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has specific active ingredient | Epinephrine bitartrate | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has active ingredient | Epinephrine | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has active ingredient | Lidocaine | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Has basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) 5 vial 5 x 20ml vials | Is pack of | False | Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Inferred relationship | Existential restriction modifier | |
| Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) 5 vial 5 x 20ml vials | Has AMP | True | Xylocaine 2% with Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials (AstraZeneca) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR